Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HXe MRI as a Biomarker for COPD Treatment Response
NCT03002389Phase 2Active, not recruiting
- Sponsor
- University of Virginia
- Start
- Nov 2017
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Anoro Ellipta, fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by University of Virginia. Started Nov 2017; status: active, not recruiting.
02
Drugs
Anoro Elliptafluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03002389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03002389.